Khaitan & Co advised Viatris on its proposed sale of stake in Biocon Biologics to Biocon for USD 815 million
Khaitan & Co advised Viatris on the USD 815 million sale of its stake in Biocon Biologics to Biocon via cash payment and preferential share allotment.